# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-28T19:18:25.860973
**Response ID:** resp_0bd24ff73433ec9700697a521e01e081969924de3f9ea967d3
**Tokens:** 9156 in / 10857 out
**Response SHA256:** c015e42fc2b3146c

---

## Fatal-error audit (journal-submission readiness)

I checked the draft only for **fatal** problems in: (1) data–design alignment, (2) regression sanity, (3) completeness, and (4) internal consistency across text/tables/figures. I did **not** assess writing, novelty, or minor modeling choices.

### 1) Data–Design Alignment (critical)
- **Treatment timing vs. data coverage:** Data are 2010–2022; treatment cohorts shown are 2011–2019 (Figure 2). **Max cohort year (2019) ≤ max data year (2022)** → OK.
- **Post-treatment observations:** Even the latest cohort (2019) has multiple post years through 2022 → OK.
- **Treatment definition consistency:** “Cohort = first full calendar year MW > $7.25; exclude partial-exposure year for mid-year effective dates” is stated consistently in Sections 3.2, A.2, and used throughout → OK.

### 2) Regression Sanity (critical)
- **Table 2:** Coefficients and SEs are in plausible ranges for percentage-point outcomes; no implausibly huge SEs; no impossible values shown → OK.
- **Table 3:** Same—magnitudes and SEs are plausible; N aligns with state×year arithmetic (balanced/unbalanced consistent with described dropping of partial-exposure years) → OK.
- No R² issues, no NA/NaN/Inf, no negative SEs observed → OK.

### 3) Completeness (critical)
- Regression tables report **N (Observations)** and **standard errors** (Tables 2 and 3) → OK.
- No placeholders like TBD/XXX/NA in tables/figures provided → OK.
- Text references to Table 1, Table 2, Figures 1–3, and Appendix tables appear to correspond to items that are present in the draft excerpt → OK.

### 4) Internal Consistency (critical)
- Main headline estimate in text/abstract (**−1.2 pp**) matches Table 2 Column 1 (**−0.012**) and the stated baseline (~0.30) matches the baseline row (**0.298**) → OK.
- Placebo claim (null for high-education) matches Table 2 Column 4 (**0.001**) → OK.
- Heterogeneity claims (65–74 stronger; $12+ larger) match Table 3 magnitudes/significance patterns → OK.

No fatal errors detected in the excerpt you provided.

ADVISOR VERDICT: PASS